Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

Letrozole may help prevent seizures by reducing certain hormone levels.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

PRP injections may be an effective treatment for severe hair loss.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Intradermal injections might work better for common hair loss than other treatments.

Analog 23 is a promising compound for prostate cancer treatment.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The treatment using a special hydrogel shows promise for promoting hair growth.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Iron chelators can effectively reduce hair loss and improve hair growth in autoimmune alopecia.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Baricitinib was effective in treating alopecia areata in two major trials.